Nutex Health Inc.
NUTX
$44.66
-$1.84-3.96%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 78.79M | 76.08M | 67.45M | 69.67M | 62.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.79M | 76.08M | 67.45M | 69.67M | 62.72M |
| Cost of Revenue | 51.91M | 48.99M | 53.11M | 51.77M | 50.91M |
| Gross Profit | 26.89M | 27.09M | 14.34M | 17.90M | 11.81M |
| SG&A Expenses | 11.83M | 10.59M | 8.71M | 9.14M | 7.84M |
| Depreciation & Amortization | 4.97M | 4.53M | 4.19M | 4.68M | 4.75M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.71M | 64.11M | 66.00M | 65.59M | 63.50M |
| Operating Income | 10.09M | 11.97M | 1.45M | 4.08M | -777.80K |
| Income Before Tax | -2.58M | 3.90M | -152.80K | -30.71M | -4.87M |
| Income Tax Expenses | 4.58M | 893.90K | 389.70K | -3.00M | -342.30K |
| Earnings from Continuing Operations | -7.17M | 3.01M | -542.50K | -27.71M | -4.52M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.62M | -3.37M | 178.40K | -3.91M | -1.02M |
| Net Income | -8.79M | -364.00K | -364.10K | -31.62M | -5.54M |
| EBIT | 10.09M | 11.97M | 1.45M | 4.08M | -777.80K |
| EBITDA | 12.15M | 14.05M | 3.41M | 6.60M | 1.11M |
| EPS Basic | -1.72 | -0.07 | -0.08 | -7.50 | -1.25 |
| Normalized Basic EPS | -0.58 | 0.65 | 0.02 | -1.00 | -0.91 |
| EPS Diluted | -1.72 | -0.07 | -0.10 | -7.86 | -1.25 |
| Normalized Diluted EPS | -0.58 | 0.65 | 0.02 | -1.00 | -0.91 |
| Average Basic Shares Outstanding | 5.10M | 4.97M | 4.85M | 4.22M | 4.43M |
| Average Diluted Shares Outstanding | 5.10M | 4.97M | 4.85M | 4.22M | 4.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -132.20% | -- | -- |
